Department of Hepatobiliary and Pancreaticosplenic Surgery, Beijing ChaoYang Hospital, Capital Medical University, Beijing, China.
Medicine (Baltimore). 2021 Jul 2;100(26):e26487. doi: 10.1097/MD.0000000000026487.
To evaluate the effect of preoperative serum alpha-fetoprotein(AFP) level to total tumor volume (TTV) ratio as a prognostic marker on predicting the tumor recurrence and overall survival time of patients with hepatocellular carcinoma (HCC) after liver transplantation.One-hundred eight patients with HCC who underwent liver transplantation in Beijing Chaoyang Hospital from April 2013 to October 2017 were studied. Divided into AFP/TTV≤2 group and AFP/TTV>2 group by the best cut-off score calculated by receiver operation characteristic curve, the clinical and pathological data of the patients in two groups were compared to explore the relationship between AFP/TTV and tumor recurrence together with the prognosis of HCC patients after liver transplantation. Risk factors of early tumor recurrence and poor prognosis of HCC in patients after liver transplantation were studied by multivariate regression analysis. Kaplan-Meier survival analysis was used to compare the tumor-free survival and overall survival between the two groups of patients.In 108 patients, 47 patients have AFP/TTV≤2 while 61 patients have AFP/TTV>2. Patients in AFP/TTV≤2 group have longer tumor-free survival time and overall survival time compared with patients in AFP/TTV>2 group. The age, total bilirubin level, serum AFP level, TTV, portal vein tumor thrombus and AFP/TTV (all P < .05) of patient with HCC are closely related to poor prognosis after liver transplantation. Multivariate regression analysis showed that have portal vein tumor thrombus (hazard ratio [HR] = 2.345, P < .05), TTV≥65.5 cm3 (HR = 2.701, P < .05) and AFP/TTV > 2 (HR = 4.624, P < .05) are independent risk factors for poor prognosis of patients with HCC after liver transplantation while TTV≥65.5 cm3 (HR = 2.451, P < .05) and AFP/TTV > 2 (HR = 4.257, P < 0.05) were independent risk factors for tumor recurrence at the same time.The tumor recurrence and the prognosis of patients with HCC after liver transplantation is affected by many factors. AFP/TTV ratio has important predictive value for the tumor recurrence and the prognosis of patients with HCC after liver transplantation. AFP/TTV>2 is an independent risk factor for both early tumor recurrence and poor prognosis of patients with HCC after liver transplantation.
目的 评价术前血清甲胎蛋白(AFP)与肿瘤总体积(TTV)比值(AFP/TTV)作为预测肝癌患者肝移植术后肿瘤复发和总生存时间的预后标志物的效果。
方法 回顾性分析 2013 年 4 月至 2017 年 10 月在北京朝阳医院行肝移植的 108 例肝癌患者的临床资料。根据受试者工作特征曲线(ROC)计算的最佳截断值,将患者分为 AFP/TTV≤2 组和 AFP/TTV>2 组,比较两组患者的临床病理资料,探讨 AFP/TTV 与肝癌患者肝移植术后肿瘤复发的关系及其对患者预后的影响。采用多因素回归分析探讨影响肝癌患者肝移植术后早期肿瘤复发和预后不良的危险因素。采用 Kaplan-Meier 生存分析法比较两组患者的无瘤生存率和总生存率。
结果 108 例患者中,47 例 AFP/TTV≤2,61 例 AFP/TTV>2。AFP/TTV≤2 组患者的无瘤生存时间和总生存时间均长于 AFP/TTV>2 组(均 P<0.05)。年龄、总胆红素水平、血清 AFP 水平、TTV、门静脉癌栓和 AFP/TTV(均 P<0.05)与肝癌患者肝移植术后预后不良密切相关。多因素回归分析显示,有门静脉癌栓(HR=2.345,P<0.05)、TTV≥65.5 cm3(HR=2.701,P<0.05)和 AFP/TTV>2(HR=4.624,P<0.05)是肝癌患者肝移植术后预后不良的独立危险因素,同时 TTV≥65.5 cm3(HR=2.451,P<0.05)和 AFP/TTV>2(HR=4.257,P<0.05)是肿瘤复发的独立危险因素。
结论 AFP/TTV 比值对肝癌患者肝移植术后肿瘤复发和预后具有重要的预测价值。AFP/TTV>2 是肝癌患者肝移植术后早期肿瘤复发和预后不良的独立危险因素。